Welcome to our dedicated page for ENSIGN GROUP SEC filings (Ticker: ENSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ensign Group, Inc. (ENSG) filings document its public-company reporting as a Delaware healthcare services company with common stock listed on the Nasdaq Global Select Market. Its disclosures cover skilled nursing and senior living operations, therapy and rehabilitative services, healthcare real estate, and the Standard Bearer real estate segment.
Ensign’s 8-K reports disclose quarterly and annual operating results and Regulation G non-GAAP measures, including adjusted net income, adjusted earnings per share, EBITDA, adjusted EBITDA, adjusted EBITDAR, adjusted EBT, and Funds from Operations for its real estate segment. Proxy materials cover shareholder voting, board governance, executive compensation, equity awards, capital-structure matters, and other governance disclosures.
Marivic Uychiat filed a Form 144 reporting a proposed sale of 67 common shares of ENSG on 02/19/2026 tied to restricted stock vesting as compensation. The filing also records 83 common shares sold during the past three months on 02/19/2026.
Ensign Group director Daren Shaw reported an open-market sale of 1,000 shares of Ensign Group common stock. The transaction occurred on February 17, 2026 at a price of $213.43 per share and was effected under a Rule 10b5-1 trading plan adopted on May 7, 2025. Following this sale, Shaw directly owns 23,726 shares of Ensign Group common stock.
ENSG filed a Form 144 proposing the sale of 500 common shares tied to options granted 02/19/2021, with the method listed as cash. The excerpt also shows prior sales by Beverly Wittekind: 8,400 shares on 12/12/2025 for $1,473,999.97 and 2,000 shares on 12/19/2025 for $360,000.00.
An individual named Daren Shaw filed a notice of proposed sale of restricted or control securities under Rule 144. The filing covers 1,000 shares of common stock to be sold through Fidelity Brokerage Services LLC on the NASDAQ, with an aggregate market value of $213,430.00.
The shares come from multiple restricted stock vesting events between 2018 and January 2026, each received as compensation from the issuer. The filing also notes that Shaw sold 1,000 common shares on 11/18/2025 for $178,570.00 in gross proceeds during the prior three months.
Wasatch Advisors reports a significant institutional stake in Ensign Group Inc/The common stock. The firm beneficially owns 2,838,566 shares, representing 4.9% of the outstanding common stock as of 12/31/2025.
Wasatch Advisors has sole voting power over 1,865,171 shares and sole dispositive (selling) power over the full 2,838,566 shares, with no shared voting or dispositive authority. The firm certifies the position is held in the ordinary course of business and not to influence control of Ensign Group.
The Ensign Group director Ann Scott Blouin reported selling 375 shares of common stock on February 9, 2026. The shares were sold at a price of $198 per share under a pre-arranged Rule 10b5-1 trading plan adopted on November 7, 2025.
After this transaction, Blouin beneficially owned 22,852 Ensign Group shares, held in direct ownership. The filing reflects a planned, programmatic sale by a board member rather than a discretionary, one-time trade.
The Ensign Group director Mark Vincent Parkinson reported a small pre-planned stock sale. On February 9, 2026, he sold 100 shares of Ensign Group common stock at $198 per share under a Rule 10b5-1 trading plan adopted on November 6, 2025. After this transaction, he directly beneficially owned 2,900 shares of Ensign Group common stock.
Ensign Group, Inc. CFO and director Suzanne D. Snapper reported stock option exercises and related common stock sales. On February 5–6, 2026, she exercised employee stock options for multiple blocks of 4,129 common shares at exercise prices of $15.80 and $15.93 per share.
On February 5–6, 2026, she sold several blocks of Ensign common stock at weighted average prices ranging from about $185.22 to $197.21 per share under a Rule 10b5-1 trading plan adopted on September 12, 2025. After these transactions, she directly owned 272,889 common shares and indirectly held 56,340 shares through the Eric and Suzanne Snapper Family Trust.
Baillie Gifford & Co has filed a Schedule 13G reporting beneficial ownership of 4,569,254 shares of Ensign Group, Inc. common stock, or about 7.89% of the class, as of December 31, 2025.
Baillie Gifford reports sole voting power over 3,924,777 shares and sole dispositive power over all 4,569,254 shares, with no shared voting or dispositive power. The filing states the securities are held in the ordinary course of business on behalf of investment advisory clients and not for the purpose of changing or influencing control of Ensign Group.